Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Digi-Tech Pharma & AI 2025

The Digi-Tech Pharma & AI Conference stands out as a premier event bringing together pharmaceutical leaders, tech innovators, healthcare professionals, regulators, and solution providers to [...]

Go to Top